Director Stephen Bloch unloads $17.8M in Liquidia stock as insider distribution wave continues
LQDA has more than doubled off its 52-week low of $16.82.
Summary
Liquidia Corp director Stephen Bloch sold $17.8 million in stock on July 22-23, continuing a 90-day trend of heavy insider selling with no offsetting purchases.
Key Events · Ownership and Investor Activity · LQDA
-
Director Sells $17.8M in Stock
Stephen Bloch sold 200,000 shares at prices between $87.70 and $90.71 on July 22-23, 2026, for total proceeds of $17,786,409. The shares were held indirectly through Canaan VIII L.P.
-
Part of Broader Insider Selling Wave
This sale contributes to a 90-day net insider selling total of $144.7 million across 13 insiders, with zero open-market purchases, signaling a persistent distribution trend.
-
Post-Sale Holdings Remain Substantial
After the sales, Bloch still holds 664,071 shares indirectly and 71,594 shares directly, indicating continued but reduced exposure.
Analysis · LQDA · Life Sciences
Director Stephen Bloch sold $17.8 million of Liquidia Corp stock over two days, adding to a wave of insider selling that has seen over $144 million in open-market sales in the past 90 days with zero insider purchases. While Bloch is not a C-suite executive and the shares were held indirectly through Canaan VIII L.P., the sale is part of a persistent distribution pattern that raises questions about insider confidence despite the company's recent strong earnings and S&P SmallCap 600 inclusion.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 30% of the 1973 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.12%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, LQDA was trading at $86.22 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $7.7B. The 52-week trading range was $16.82 to $91.10. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.